Tulavi Therapeutics Appoints Raymond W. Cohen as Vice Chairman of Board of Directors
Raymond W. Cohen, a seasoned executive with a track record of building and scaling innovative medical device companies, has been appointed Vice Chairman of the Board of Directors at Tulavi Therapeutics, Inc., a medical device company transforming peripheral nerve surgery with its Adaptive Hydrogel Technology. Cohen brings expertise in hydrogels, neurology, and device markets, and his appointment is seen as a significant development in Tulavi's growth trajectory. As CEO, Cohen has overseen the development and commercialization of several medical device companies, including Axonics, Inc., which he co-founded in 2013 and took public in 2018.
Key Takeaways:
- Raymond W. Cohen has been appointed as the Vice Chairman of the Board of Directors at Tulavi Therapeutics, Inc.
- Cohen has a track record of building and scaling innovative medical device companies, including Axonics, Inc., which he co-founded in 2013 and took public in 2018.
- Cohen's expertise in hydrogels, neurology, and device markets will be instrumental in advancing Tulavi's Adaptive Hydrogel Technology and expanding access to peripheral nerve surgery.
- Cohen has previously served as CEO and chairman of various medical device companies, including Axonics, Inc., and has overseen the development and commercialization of several medical devices.
- He has also served on the boards of companies such as SoniVie, Ltd, and Kestra Medical Technologies.
Statistics:
- 2013: Axonics, Inc. was co-founded by Cohen.
- 2018: Axonics, Inc. went public, with Cohen serving as CEO and member of the board of directors.
- 2021 and 2022: Axonics ranked No. 1 on the Deloitte Technology Fast 500 and the Financial Times fast-growing companies in the Americas.
- 2025: Cohen retired as CEO of Axonics, and was named Chairman of the Board of SoniVie, Ltd.
Sources:
- News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week (July 6, 2025)
- Not specified